Effect of nateglinide on the postprandial triglyceride and lipoprotein concentrations in subjects at risk for type 2 diabetes

被引：0
|
作者：
Johanson, E
Axelsen, M
Jansson, PA
Taskinen, MR
Smith, U
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A211 / A211
页数：1
相关论文
共 50 条
  • [21] Effect of Overweight and Obesity on Postprandial Lipemia among the Subjects with Type 2 Diabetes
    Nadia, Amrane
    Boumediene, Khaled Meghit
    JOURNAL OF DIABETES & METABOLISM, 2012, 3 (02)
  • [22] Nateglinide for type 2 diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2001, 43 (1101): : 29 - 30
  • [23] Nateglinide - A new member of the meglitinide family for postprandial glucose control in type 2 diabetes
    Schrand, LM
    Spanheimer, RG
    FORMULARY, 2000, 35 (10) : 798 - +
  • [24] Comparison of the effects of nateglinide and glibenclamide on postprandial glucose and lipid fluxes in Type 2 diabetes
    Dimitriadis, G
    Boutati, E
    Lambadiari, V
    Mitrou, P
    Maratou, E
    Houssianakou, E
    Raptis, S
    DIABETOLOGIA, 2002, 45 : A245 - A245
  • [25] Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: The relationship to triglyceride-rich postprandial lipoprotein composition
    Phillips, Catherine
    Mullan, Karen
    Owens, Daphne
    Tomkin, Gerald H.
    ATHEROSCLEROSIS, 2006, 187 (01) : 57 - 64
  • [26] Effect on chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia
    Tai, TS
    Sheu, WHH
    Lee, WJ
    Yao, HT
    Chiang, MT
    DIABETES CARE, 2000, 23 (11) : 1703 - 1704
  • [27] Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial metabolism, coagulation, and fibrinolysis (vol 15, pg 6, 2005)
    Tentolouris, N
    Boutati, E
    Karambakalis, N
    Perrea, D
    Tselepis, AD
    Tsoukala, C
    Kyriaki, D
    Lourida, E
    Anastasopoulou, I
    Karafoullidou, A
    Raptis, SA
    Katsilambros, N
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2006, 16 (01) : 81 - 81
  • [28] Nateglinide and Acarbose Are Comparably Effective Reducers of Postprandial Glycemic Excursions in Chinese Antihyperglycemic Agent-Naive Subjects with Type 2 Diabetes
    Zhou, Jian
    Li, Hong
    Zhang, Xiuzhen
    Peng, Yongde
    Mo, Yifei
    Bao, Yuqian
    Jia, Weiping
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (06) : 481 - 488
  • [29] Mean postprandial triglyceride concentration is an independent risk factor for carotid atherosclerosis in patients with type 2 diabetes
    Idei, Mayumi
    Hirayama, Satoshi
    Miyake, Noriko
    Kon, Mika
    Horiuchi, Yuki
    Ueno, Tsuyoshi
    Miyake, Kazunori
    Satoh, Naotake
    Yoshii, Hidenori
    Yamashiro, Keiko
    Onuma, Tomio
    Miida, Takashi
    CLINICA CHIMICA ACTA, 2014, 430 : 134 - 139
  • [30] Effects of Nateglinide Versus Acarbose on Postprandial Plasma Glucose Excursion and Postprandial Lipid Profiles in Patients with Type 2 Diabetes
    Lu, Juming
    Lv, Xiaofeng
    Xue, Yaoming
    Guo, Xiaohui
    Li, Yanbing
    Yan, Li
    DIABETES, 2011, 60 : A291 - A292
12345